Enteric Plesiomonas shigelloides infections in Finnish patients.
Plesiomonas shigelloides was isolated from 20/13,027 stool samples submitted for culture to the Department of Bacteriology and Immunology, University of Helsinki, in 1990. All except 2/20 Plesiomonas-positive patients had diarrhea; 13 patients had acute onset of illness after foreign travel and 5 patients had chronic diarrhea with symptoms lasting > or = 2 months. Travel destinations were outside Europe in most cases. In 12 cases Plesiomonas was isolated in pure culture and in 8 cases together with other enteropathogens. All isolates were susceptible to ciprofloxacin, doxycycline, trimethoprim and sulfamethoxazole, gentamicin, cephalexin, cefuroxime, ceftriaxone and cefixime.
Rautelin
H
H
Department of Bacteriology, University of Helsinki, Finland.
Sivonen
A
A
Kuikka
A
A
Renkonen
O V
OV
Valtonen
V
V
Kosunen
T U
TU
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D004352:Drug Resistance, Microbial; D005243:Feces / Q000382:microbiology; D005260:Female; D005387:Finland / Q000453:epidemiology; D005759:Gastroenteritis / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D016981:Plesiomonas / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity; D014195:Travel